Crane Biosciences

Company profile

Crane Biosciences company profile

Crane Biosciences specializes in the development of innovative gene therapies using red blood cell-derived nanoparticles (RBCNPs). These therapies are designed to be invisible to the immune system, addressing a critical challenge in gene therapy by preventing immune system reactions. The company's approach aims to revolutionize the treatment of diseases caused by genetic mutations, potentially offering cures and improving the lives of millions. Crane Biosciences combines biotechnology expertise with AI to enhance the development of its gene therapies, focusing on making a significant impact on human health through scientific innovation.